PLANNING permission has been granted for the facility that will house the UK’s Vaccines Manufacturing and Innovation Centre (VMIC).
VMIC, based at Harwell Campus in Oxfordshire, will provide the UK’s first bespoke strategic vaccine development and manufacturing capability. Vale of White Horse District Council allowed construction to begin whilst simultaneously processing the planning application because of the critical nature of the facility and the role it will play in manufacturing vaccines for Covid-19 and beyond.
Chris Lucas, chief operating officer at VMIC said, “By fast-tracking the planning process and allowing us to start construction of the VMIC facility early, the district council has really enabled us to accelerate the pace of this project. Their support and collaborative approach has contributed significantly towards us meeting our deadline of opening in summer 2021 – a year ahead of schedule.”
Eddie McGillycuddy, MD of Glencar Construction added, “Glencar is delighted to play a central role in the realisation of this landmark project. From the outstanding approach of the Vale of White Horse and Harwell Campus to the contractors and suppliers on site, it has been a leading example of the Construction industries capabilities. Together, we will bring this facility to operational status in record time.”
